Charles River Laboratories, Inc. Sustainability Profile
Charles River Laboratories, Inc., commonly referred to as Charles River, is a leading global provider of preclinical and clinical laboratory services. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, serving a diverse clientele in the pharmaceutical, biotechnology, and medical device industries. Founded in 1947, Charles River has achieved significant milestones, including the expansion of its service offerings and strategic acquisitions that enhance its market position. The company specialises in a range of services, including drug discovery, safety assessment, and laboratory animal medicine, distinguished by its commitment to quality and innovation. With a strong reputation for scientific excellence, Charles River is recognised for its contributions to advancing healthcare and improving patient outcomes, solidifying its status as a trusted partner in the life sciences sector.
DitchCarbon Score
How does Charles River Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Charles River Laboratories, Inc.'s score of 62 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Charles River Laboratories, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Charles River Laboratories International, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Charles River Laboratories, Inc. However, emissions data and climate initiatives may be inherited from its parent company, Charles River Laboratories International, Inc. This includes participation in various sustainability initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from the parent organisation. While specific emissions figures are not provided, the company's involvement in these initiatives suggests a commitment to addressing climate change and reducing carbon footprints in alignment with industry standards. Further details on their climate strategy and performance may be available through the parent company's disclosures.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 86,284,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 79,271,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Charles River Laboratories, Inc.'s Industry?
How Carbon Intensive is Charles River Laboratories, Inc.'s Location?
Charles River Laboratories, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Charles River Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
